Search for Clinical Trial Results

Hypoparathyroidism - 25 Studies Found
Status | Study |
Completed |
Study Name: Use of NPSP558 in the Treatment of Hypoparathyroidism Condition: Hypoparathyroidism Date: 2008-08-08 Interventions:
|
Completed |
Study Name: Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY) Condition: Hypoparathyroidism Date: 2010-12-28 Interventions: Drug: NPSP558 All patients will inject NPSP558 25 or 50 µg SC QD into alternating thighs in the mor |
Terminated |
Study Name: Teriparatide for Postsurgical Hypoparathyroidism Condition: Hypoparathyroidism Post-surgical Date: 2010-07-27 Interventions: Drug: Teriparatide The dose of teriparatide will be 20 mcg twice daily for the first week and 20 mcg dai |
Recruiting |
Study Name: Survey on Epidemiology of Hypoparathyroidism in France Condition: Hypoparathyroidism Date: 2016-07-09 Interventions: Other: No intervention No intervention |
Completed |
Study Name: Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life Condition: Hypoparathyroidism Date: 2008-08-04 Interventions:
|
Completed |
Study Name: Magnesium Treatment in Hypoparathyroidism Condition: Hypoparathyroidism Date: 2009-01-15 Interventions: Dietary Supplement: magnesium magnesium 350 mg tablets once a day for 3 weeks |
Completed |
Study Name: Hypoparathyroidism in Denmark Condition: Hypoparathyroidism Date: 2011-12-20 |
Completed |
Study Name: Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34 Condition: Hypoparathyroidism Date: 1999-11-03 Interventions:
|
Completed |
Study Name: A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary Condition: Hypoparathyroidism Date: 2011-09-15 Interventions: Drug: NPSP558 50, 75, 100 μg Other Name: REPEAT |
Active, not recruiting |
Study Name: A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE) Condition: Hypoparathyroidism Date: 2011-02-11 Interventions: Drug: NPSP558 All patients will inject NPSP558 individual titration of 25, 50, 75 or 100 μg SC QD i |